Youth 6 to less than 18 years old with chronic plaque psoriasis for at least 6 months, may qualify to participate in this study. Individuals must have plaque psoriasis inadequately controlled with phototherapy and/or topical therapy, as well as moderate to severe disease severity at the time of study entry.

Participants will receive study medication via injection depending on which part they are enrolled in:

• Part 1: either active investigational medication, placebo or active comparator
• Part 2: active investigational medication

Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Participation will last about 74 weeks and include about 12-16 visits to the study centre. Participants may then be offered the opportunity to participate in a long-term extension of the study.

Call the study centre near you or register now.